Almirall + Evotec = first-in-class dermatological therapies
Published on 30/10/2018
Almirall S.A. and Evotec AG have entered into a research collaboration to discover and develop first-in-class therapies for debilitating dermatology diseases
Almirall seeks novel targets for skin health
Published on 10/10/2018
We provide research funding for work on novel targets and concepts which may form the basis for new medicines in dermatological diseases
Adding value to your assets, AlmirallShare new call
Published on 19/06/2018
Almirall seeks new compounds to treat atopic dermatitis, psoriasis, actinic keratosis, acne, and related dermatological diseases.
More than 100 proposals received at AlmirallShare
Published on 09/03/2018
Scientists from all over the world have been registered on AlmirallShare and submit their solutions to improve skin health.
One month left to participate in Preclinical Models call
Published on 29/11/2017
Deadline of December, 31th, 2017. Preclinical Models call is offering financial and scientific support to develop novel pharmacologically validated in vitro and in vivo research translational preclinical models in skin...